Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta

Author： Mochida H.   Inoue H.   Takagi M.   Noto T.   Yano K.   Kikkawa K.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.440, Iss.1, 2002-04, pp. : 45-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum

By Takagi M.   Mochida H.   Noto T.   Yano K.   Inoue H.   Ikeo T.   Kikkawa K.  

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

T-1032, a novel specific phosphodiesterase type 5 inhibitor, increases venous compliance in anesthetized rats

By Inoue H.   Yano K.   Ikeo T.   Noto T.   Kikkawa K.  

European Journal of Pharmacology, Vol. 422, Iss. 1, 2001-06 ,pp. : 109-114

Elsevier

Access to resources Recommend Favorite

Pyridazine Derivatives XIV. Study of the Vasorelaxant Action of 6-Aryl-5-Piperidino-3-Hydrazinopyridazines in Isolated Rat Thoracic Aorta: Comparison with Hydralazine

By Campos-Toimil M.   Estevez I.   Ravina E.   Orallo F.  

General Pharmacology, Vol. 30, Iss. 2, 1998-02 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite

Vasorelaxant properties of brefeldin A in rat aorta

By Filipeanu C.M.   Brailoiu E.   Costuleanu M.   Costuleanu A.   Toma C.P.   Branisteanu D.D.  

European Journal of Pharmacology, Vol. 332, Iss. 1, 1997-07 ,pp. : 71-76

Elsevier

Access to resources Recommend Favorite

Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil

By Gibson A.  

European Journal of Pharmacology, Vol. 411, Iss. 1, 2001-05 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite